Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Retained Earnings

The Retained Earnings of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 3.24 B CNY. In the previous year, Retained Earnings was 3.15 B CNY — a change of 2.94% (higher).

Retained Earnings

3.24 BCNY

YoY

2.94%

Last updated:

Retained Earnings of Jinyu Bio-Technology Co is 2025 3.24 B CNY. Retained Earnings of Jinyu Bio-Technology Co was 2024 3.15 B CNY. It decreases by 2.94% higher compared to the previous year.

The Jinyu Bio-Technology Co Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
2.63 B CNY
Jan 1, 2019
2.37 B CNY
Jan 1, 2020
2.69 B CNY
Jan 1, 2021
2.90 B CNY
Jan 1, 2022
2.96 B CNY
Jan 1, 2023
3.16 B CNY
Jan 1, 2024
3.15 B CNY
Jan 1, 2025
3.24 B CNY
The Jinyu Bio-Technology Co Retained Earnings history
YEARRetained EarningsYoY
3.24 BCNY+2.94%
3.15 BCNY-0.58%
3.16 BCNY+6.84%
2.96 BCNY+1.99%
2.90 BCNY+8.10%
2.69 BCNY+13.42%
2.37 BCNY-10.12%
2.63 BCNY+18.32%
2.23 BCNY+29.32%
1.72 BCNY+27.18%
1.35 BCNY+35.82%
996.77 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Retained Earnings of Jinyu Bio-Technology Co is 3.24 B CNY in 2025.

Retained Earnings of Jinyu Bio-Technology Co changed from 3.15 B CNY to 3.24 B CNY, representing a 2.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Jinyu Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Jinyu Bio-Technology Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Jinyu Bio-Technology Co